# VELETRI
> **NDA022260** · New Drug Application · Sponsor: ACTELION · Approved 2008-06-27
## Drug
- **FDA Application Number:** NDA022260
- **Application type:** New Drug Application
- **Brand name:** VELETRI
- **Generic name:** EPOPROSTENOL
- **Active ingredients:** EPOPROSTENOL SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ACTELION
- **Manufacturer:** Actelion Pharmaceuticals US, Inc.
- **First approval:** 2008-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022260)
---
*MORVS · CC0 1.0*